HSBC Holdings’s Sucampo Pharmaceuticals SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-443,948
Closed -$7.97M – 2651
2017
Q4
$7.97M Buy
+443,948
New +$5.47M 0.01% 735

Other funds holding SCMP

HSBC Holdings's SCMP Position: Q1 2018 in Review

HSBC Holdings sold out of Sucampo Pharmaceuticals (SCMP) in Q1 2018, closing a stake of 443,948 shares — an estimated $7.97M sold.

HSBC Holdings first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $7.97M in Q4 2017. 2 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • HSBC Holdings reported no remaining Sucampo Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • HSBC Holdings sold 443,948 Sucampo Pharmaceuticals shares in Q1 2018, an estimated $7.97M.
  • HSBC Holdings first reported a position in Sucampo Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • HSBC Holdings's Sucampo Pharmaceuticals position peaked at $7.97M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals as of Q1 2018.

Based on HSBC Holdings's 13F filing for Q1 2018, filed 11 May 2018.